Tantti

Taoyuan City, Taiwan Founded: 2014 • Age: 12 yrs Acquired By Repligen
Tools for self-assembly based ordered nanostructures are developed.

About Tantti

Tantti is a Healthcare company based in Taoyuan City (Taiwan) founded in 2014, and was acquired by Repligen in July 2024. Tools for self-assembly based ordered nanostructures are developed. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.

Company details

Tantti has developed tools for synthesis of self-assembly based ordered nanostructures. The core technology of the company synthesize uniform microspheres from 100 nm to 5000 nm and generate unified air bubbles from 60 µm to 500 µm via a microfluidic device. They can be applied in bio-scaffolds, skin substitutes, monolithic columns, bio-reactor, separation media, and sensors. The collagenbiomaterial scaffolds developed using this technology has shown potentials in areas of 3D cell culture, skin substitute, injectable scaffolds, and regenerative medicine. Additionally, the company offers contract research services.

  • Headquarters Taoyuan City, Taiwan
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website tantti.com
  • Social LinkedIn X YouTube
  • Acquired by Repligen (Jul 2024)
Key Metrics

Apps and channels of Tantti

its YouTube channel 台灣創新材料股份有限公司 Tantti Laboratory Inc. has 55 subscribers and 22 videos.

台灣創新材料股份有限公司 Tantti Laboratory Inc.
YouTube 55 subscribers 22 videos Science & Technology
Open channel

Videos from Tantti

The most watched videos on Tantti's YouTube channel, 台灣創新材料股份有限公司 Tantti Laboratory Inc. (55 subscribers). Click a video to play it here.

台創材兩大獨步全球之技術平台
1K views
Stem Cell expansion on UniTantrix in spinner flask bioreactor (EN Subtitle)
455 views
UniTantrix® を用いたスピンナフラスコバイオリアクターにおける幹細胞の増幅
455 views
UniTantrix® 應用於旋轉攪拌瓶生物反應器中的幹細胞擴增技術_繁中
452 views

More on 台灣創新材料股份有限公司 Tantti Laboratory Inc..

Investors in Tantti

Tantti has secured backing from 1 investor. Prominent investors backing the company include Repligen.

All
InvestorDescriptionFounded YearDomainLocation
Products and services for biologic drug manufacturing are supplied.
1981repligen.comWaltham, United States
Premium access

Investor details for Tantti

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Tantti

2 dated milestones of Tantti across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Tantti is founded.
  2. Exit Acquired by Repligen.

Web traffic of Tantti

The website of Tantti (tantti.com) receives about 1.4K visits a month.

  • Monthly visits
    1.4K
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Tantti

Premium access

Complete news archive for Tantti

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tantti

Tantti was founded in 2014.

Tantti is headquartered in Taoyuan City, Taiwan.

Tantti has developed tools for synthesis of self-assembly based ordered nanostructures. The core technology of the company synthesize uniform microspheres from 100 nm to 5000 nm and generate unified air bubbles from 60 µm to 500 µm via a microfluidic device. They can be applied in bio-scaffolds, skin substitutes, monolithic columns, bio-reactor, separation media, and sensors. The collagenbiomaterial scaffolds developed using this technology has shown potentials in areas of 3D cell culture, skin substitute, injectable scaffolds, and regenerative medicine. Additionally, the company offers contract research services.

Tantti has 1 investor. Key investors include Repligen.

Yes. Tantti was acquired by Repligen in July 2024.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available